戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ing pathogen uptake, antigen processing, and immunomodulation.
2 host organelles, many of which have roles in immunomodulation.
3 cellular differentiation, proliferation, and immunomodulation.
4 onse and a PD-L1-dependent allogeneic-driven immunomodulation.
5 tion for the purpose of cancer treatment and immunomodulation.
6 ive approach to upregulate Tregs and achieve immunomodulation.
7 pressor cells primarily implicated in cancer immunomodulation.
8 promising target for small molecule-directed immunomodulation.
9  with the immune system and how they mediate immunomodulation.
10 ific biomarker for type 1 diabetes onset and immunomodulation.
11 further characterising the effects of FOs on immunomodulation.
12 e, they are valuable therapeutic targets for immunomodulation.
13 o inform new therapeutic strategies based on immunomodulation.
14 that depletes lymphocytes, causing long-term immunomodulation.
15 regulation and suggest unique strategies for immunomodulation.
16  Polysaccharide and lipid components promote immunomodulation.
17 is via targeted depletion of macrophages and immunomodulation.
18 or the role of glucocorticoids in MW-induced immunomodulation.
19 s, and massive lymphocyte apoptosis prevents immunomodulation.
20  use in T cells may reveal novel targets for immunomodulation.
21  as a novel potential target for therapeutic immunomodulation.
22 ted to provide therapeutic immunosuppression/immunomodulation.
23 velopment and, in some parasitic species, in immunomodulation.
24 utinin (FHA) that functions in adherence and immunomodulation.
25 apeutic approach to achieve antigen-specific immunomodulation.
26 VEM function during HSV infection: entry and immunomodulation.
27 ing that A35 increases poxvirus virulence by immunomodulation.
28  present potential pharmacologic targets for immunomodulation.
29  Cell Death 1 (PD-1) plays a crucial role in immunomodulation.
30 al design will potentially expand to include immunomodulation.
31 constituting a unique target for therapeutic immunomodulation.
32 ue regeneration may, in reality, result from immunomodulation.
33 eceptor modulation in lungs is essential for immunomodulation.
34 t disease (TA-GVHD), and transfusion-induced immunomodulation.
35 bute to eosinophil-mediated inflammation and immunomodulation.
36 f Lck could be a useful adjunct for enhanced immunomodulation.
37 hat the beneficial effect of NECA was due to immunomodulation.
38  as well as efforts to engineer peptides for immunomodulation.
39 he T cell may represent a useful approach to immunomodulation.
40 e function of Treg in the CNS, distinct from immunomodulation.
41  provide a new strategy for HIV therapies or immunomodulation.
42 ssion of genes important in host defense and immunomodulation.
43  with focused activity that permit selective immunomodulation.
44  enzyme inhibition, antioxidant, opioid, and immunomodulation.
45 responsive murine CD4+ T cells, resulting in immunomodulation.
46 stence of a novel mechanism of TLR4-mediated immunomodulation.
47 efficacy may be affected by parasite-induced immunomodulation.
48 fense, surfactant homeostasis, and pulmonary immunomodulation.
49 in cellular proliferation, angiogenesis, and immunomodulation.
50 giectasia (HHT), cancer, atherosclerosis and immunomodulation.
51 esponse has made it an attractive target for immunomodulation.
52 go, work that ultimately led to the study of immunomodulation.
53 al activities of glucocorticoids, especially immunomodulation.
54 stem and, as such, are important targets for immunomodulation.
55 esistance or to alter the plant phenotype by immunomodulation.
56 d assessing innovative therapies directed at immunomodulation.
57 mong such receptors may play a role in their immunomodulation.
58 aid in identifying subtypes more amenable to immunomodulation.
59 anisms: malignant cell killing and TAM-based immunomodulation.
60  variety of homeostatic functions, including immunomodulation.
61 imates in the setting of clinically relevant immunomodulation.
62  scale that provides new insights into viral immunomodulation.
63 the level of these antibodies was lowered by immunomodulation.
64 genesis of severe pneumonia and a target for immunomodulation.
65 SHED-mediated osteogenic differentiation and immunomodulation.
66 whereas the CD56bright subset is involved in immunomodulation.
67 ng cytokine partial agonists for therapeutic immunomodulation.
68 esent therapeutic targets for anti-CD132 mAb immunomodulation.
69 ify TGF-beta2 as the crucial mediator of NPC immunomodulation.
70 lecule has been shown to provide therapeutic immunomodulation.
71 nt, with further evidence of strain-specific immunomodulation.
72  for antimetabolite or calcineurin inhibitor immunomodulation.
73 cytostatics, the molecular mechanisms of its immunomodulation ability have not been investigated thor
74                                              Immunomodulation aimed at maximizing the beneficial effe
75           Finally, RNS60 treatment exhibited immunomodulation and ameliorated adoptive transfer of ex
76  The pleiotropic effects of statins, such as immunomodulation and anti-inflammatory effects, may also
77  enable insight into potential mechanisms of immunomodulation and broaden our understanding of the te
78 IFN-alpha, an antiviral cytokine involved in immunomodulation and control of HIV type 1 replication,
79 R2 by Bryo-1 has significant implications in immunomodulation and could overcome some of the immune d
80 strategies for treating cancer have involved immunomodulation and cytokine gene transfer using viral
81 hMSC) and mouse mesenchymal stem cell (mMSC) immunomodulation and differentiation, depending on the i
82 yltryptophan conjugates 1 and 2 for combined immunomodulation and DNA cross-link-triggered apoptosis
83 d survival but also facilitate tumor-induced immunomodulation and eventual metastasis.
84 n disease pathogenesis, contributing to both immunomodulation and host tissue injury.
85 may identify breast cancers more amenable to immunomodulation and indicate additional strategies to e
86 repair through mechanisms that involved both immunomodulation and induction of neurotrophic factors.
87  effect of vitamin D on lung development and immunomodulation and present the evidence of its role in
88  are relevant to depression: synaptogenesis, immunomodulation and regulation of glycogen synthase kin
89          Up to 20% of patients relapse after immunomodulation and require additional treatment.
90 nt clinical significance in helminth-induced immunomodulation and sepsis.
91 d the molecular mechanisms underpinning such immunomodulation and show here that ES-62-mediated downr
92  and cancer, applied to immune surveillance, immunomodulation and the functions of IgE-mediated immun
93 lso discussed as a potential drug target for immunomodulation and the treatment of leukemia.
94 an primates point to a broader role for PD-1 immunomodulation and to potential applications in humans
95                               The pattern of immunomodulation and transcriptional dysregulation induc
96 hese findings identify potential targets for immunomodulation and treatment to combat lethal WNV infe
97 atients failed to convert with pretransplant immunomodulation and were not transplanted; 51 underwent
98 ent a new class of targeted therapeutics for immunomodulation and/or cancer therapy.
99 rs of fibrosis, angiogenesis, proliferation, immunomodulation, and antimicrobial activity suggest tha
100 s, including attachment to epithelial cells, immunomodulation, and competitive exclusion of pathogens
101 narinone's ability to suppress inflammation, immunomodulation, and growth regulation.
102 volume expansion, natriuresis, hemodilution, immunomodulation, and improved pulmonary gas exchange.
103 e been linked to glioma invasive properties, immunomodulation, and increased angiogenesis, leading to
104 e engineering: multilineage differentiation, immunomodulation, and production of trophic factors.
105  approaches to find a better adjuvant, focus immunomodulation, and reduce allergenicity are under inv
106  plays important roles in neurotransmission, immunomodulation, and regulation of cell proliferation.
107 on the skin include tanning, carcinogenesis, immunomodulation, and synthesis of vitamin D, among othe
108 l role for FHA in B. bronchiseptica-mediated immunomodulation, and they suggest a role for FHA in hos
109                     Therefore, inflammation, immunomodulation, apoptosis, and differentiation are on
110 ence, treatment strategies that are based on immunomodulation are on the rise.
111 n, the development of cancer stem cells, and immunomodulation are plausible underlying mechanisms by
112 ts, the molecular mechanisms underlying this immunomodulation are poorly characterized.
113 eir in vivo efficacy and persistence by host immunomodulation are presented in the context of an ever
114 macaques infected without the need for prior immunomodulation as is required for some other models.
115 fe and well tolerated and caused significant immunomodulation at a low dose.
116 ure directions include therapies targeted at immunomodulation, at angiogenesis, and in particular aga
117 ovides an additional rationale for exploring immunomodulation-based therapies that could reduce disea
118 ing to anergy and apoptosis; however, active immunomodulation by accumulating tryptophan catabolites,
119                                              Immunomodulation by anti-P1 MAbs represents a useful str
120  expression in M-MDSCs accounts for positive immunomodulation by chemotherapeutic agents.
121 rphogenesis, with potential implications for immunomodulation by HCMV, and may also be a mechanism by
122                                              Immunomodulation by HLA-DQA1 is effective in vivo becaus
123 an important, often overlooked, mechanism of immunomodulation by PUFAs.
124                                              Immunomodulation by Siglecs has been extensively studied
125 C-mediated molecular mechanism that triggers immunomodulation by targeting Kv1.3 in leukocytes.
126 hese data establish a mechanism for systemic immunomodulation by the microbiota and highlight potenti
127 o our understanding of the mechanisms behind immunomodulation by the RRV vIRFs during infection.
128  survival of the parasites, helminth-induced immunomodulation can also have a number of benefits for
129 antitumor immune effectors elicited by local immunomodulation can eradicate tumor cells at distant si
130 e data show that nondiabetogenic regimens of immunomodulation can lead to prolonged islet allograft s
131 tiviral and antimicrobial defense, including immunomodulation, cell cycle regulation, cell survival,
132 and evaluated mechanisms by which beneficial immunomodulation could occur in this system.
133 proteins, which are therefore treatable with immunomodulation, could account for some cases of idiopa
134                            Pregnancy-induced immunomodulation, defined as a lack of appropriate cellu
135 lation maintained, and a mechanism for S1PR1 immunomodulation described.
136                                              Immunomodulation (desensitization) protocols may reduce
137           These findings suggest that opioid immunomodulation directed at host T cells may be adjunct
138 rednisolone on microvascular dysfunction and immunomodulation during IRI in rat cardiac allografts su
139 r perioperative TPE are typically related to immunomodulation during solid-organ transplant.
140 nological adjuvants were incorporated, their immunomodulation effect for cytokine TNF-alpha and IL-6
141 es to prevent viral infections, based on the immunomodulation faces many problems related to the ecto
142 es, thus pointing towards a new direction of immunomodulation for SCI repair.
143 he potential usefulness of parasite-mediated immunomodulation for the treatment and prevention of a r
144 ition and osteoclastic tissue resorption and immunomodulation for tissue development.
145                                              Immunomodulation frequently occurs during viral infectio
146                             Furthermore, the immunomodulation function of anti-CD40 was associated wi
147                                              Immunomodulation had no impact on the amount of cardiac
148                                              Immunomodulation has been shown to be effective in treat
149 t, gene-directed enzyme prodrug therapy, and immunomodulation have been recently investigated with po
150           We also propose a diversity-driven immunomodulation hypothesis that may explain the delayed
151 hocytes as a novel approach for T lymphocyte immunomodulation in autoimmune diseases without affectin
152  widely regarded as a therapeutic target for immunomodulation in autoimmune diseases.
153  warranting further investigation of CD81 in immunomodulation in cancer and its progression.
154  NF-kappaB pathway as a potential target for immunomodulation in HAM/TSP.
155 ever, the mechanisms of maraviroc-associated immunomodulation in human immunodeficiency virus (HIV)-i
156         For studies that explore therapeutic immunomodulation in multiple sclerosis, rigorous monitor
157 ropathy, and scleritis in patients requiring immunomodulation in patients who have failed or who are
158                                  Testing for immunomodulation in PBMC cells shows the induction of th
159            CDK9 activity may be a target for immunomodulation in RSV-induced lung disease.
160 dies underscore the complex nature of PGE(2) immunomodulation in the context of host-microbial intera
161 also have implications in immune evasion and immunomodulation in the human host.
162 ying the therapeutic effects of NSCs include immunomodulation in the periphery and the central nervou
163 elta1 ligand as a potential novel target for immunomodulation in transplantation.
164 tes and the short- and long-term benefits of immunomodulation in ulcerative colitis.
165                       Cellular therapies for immunomodulation in vascularized composite allotransplan
166  In this study, we studied whether concerted immunomodulation in vivo by CTLA4Ig depends on IDO.
167 g a possible mechanism for galectin-mediated immunomodulation in vivo.
168                                              Immunomodulation, in particular improvement of the host
169 ortant roles in defense, microbial adhesion, immunomodulation, inflammation, and cancer.
170                                              Immunomodulation involves the use of antibodies to alter
171                           Here, we report an immunomodulation involving the Bordetella bronchiseptica
172                                              Immunomodulation is a common feature of chronic helminth
173                                              Immunomodulation is a promising strategy in anticancer t
174 mmune response to infection and suggest that immunomodulation is an additional mechanism by which the
175                  Prophylactic or therapeutic immunomodulation is an antigen-independent strategy that
176                                              Immunomodulation is emerging as an effective means of sh
177                              Sustained viral immunomodulation is implicated in a variety of inflammat
178  vertebrate immunity, we also show that host immunomodulation is implicated in the deleterious phenot
179 ny of the studies concluded that BMSC-driven immunomodulation is mediated by the suppression of proin
180                                           As immunomodulation is not devoid of deleterious side effec
181                              Evasion through immunomodulation is one of the several strategies adopte
182       Despite years of use, its mechanism of immunomodulation is still unclear.
183                             Helminth-induced immunomodulation is thought to influence the outcome of
184 tivate TLR2-signaling and that TLR2-mediated immunomodulation is unlikely to play a significant role
185 ive development of numerous biomaterials for immunomodulation, it is only recently that an experiment
186 re, we identified another mechanism of BILF1 immunomodulation: it targets newly synthesized MHC-I/pep
187  of infection through transfusion-associated immunomodulation leading to sepsis and sepsis-induced lu
188 ific attention is turned to their effects on immunomodulation, lipid metabolism, cancer prevention, d
189 cination argues that neutralization of viral immunomodulation may be a new vaccine paradigm for HCMV
190 nsive evidence suggests that this innovative immunomodulation may be a safe approach to ameliorate al
191      Manipulation of Tregs or other types of immunomodulation may become a part of AML treatment in t
192 echanisms underlying stress effects on fetal immunomodulation may differ based on maternal atopic sta
193                                 Non-specific immunomodulation may have a role as a potential treatmen
194                 Results suggest that chronic immunomodulation may prevent recurrent optic neuritis an
195 he surgical patient, yet transfusion-related immunomodulation may underlie the association of allogen
196  CD8(+) effector response and reducing local immunomodulation mediated by CD8(+) regulatory T cells.
197     This demonstrates that clinically useful immunomodulation mediated by the S1P(1) receptor can be
198      We therefore tested the hypothesis that immunomodulation might counteract this pathophysiologica
199 will require a combination of strategies for immunomodulation, neuroprotection, and myelin replacemen
200                    Overall, helminth-related immunomodulation observed in MS patients was mediated by
201    These data indicate that helminth-induced immunomodulation occurs independently of changes in the
202 athway as a potentially important target for immunomodulation of atherosclerosis.
203 emokines and their receptors are involved in immunomodulation of atopic asthma.
204 population may play an important role in the immunomodulation of CL.
205 fects of IVIG therapy can be mediated by the immunomodulation of DCs, creating a bridge that induces
206                                              Immunomodulation of distinct monocyte subsets has recent
207 ffect of CoPP therapy seemed to be caused by immunomodulation of donor cells, because treatment of ce
208                                              Immunomodulation of FcgammaRIIb in clinical transplantat
209 g inflammation during AAA formation and that immunomodulation of IL-17 by MSCs can offer protection a
210 s that T regulatory cells may play a role in immunomodulation of immune responses by parasitic helmin
211  the current study was to explore whether an immunomodulation of infant responses could enhance prote
212 minating bacteria without lysis coupled with immunomodulation of inflammation should be pursued clini
213 model to address the potential mechanisms of immunomodulation of liver disease by creating two unique
214 ies in different tumor models revealed broad immunomodulation of lymphoid and myeloid cells by ADC an
215 gments may greatly facilitate the successful immunomodulation of metabolic pathways in many organisms
216 iming affinity and have implications for the immunomodulation of pathogenic T cell responses during t
217  on CD4(+) T cells have implications for the immunomodulation of pathologic T cell responses during t
218 y studies are showing promising results with immunomodulation of response to injury.
219 vising novel therapeutic strategies aimed at immunomodulation of skewed effector T cell responses.
220  support an important role for infection and immunomodulation of T cells in clinical human disease.
221 link targeted immune cells with the elicited immunomodulation of T cells.
222 success as parasites is the result of active immunomodulation of the host immune response, which can
223        Together, these results indicate that immunomodulation of the host response may be an alternat
224 l cells, inhibition of bacterial growth, and immunomodulation of the host.
225 1 receptor can benefit from augmentation and immunomodulation of the immune response.
226 e parasites' success is the result of active immunomodulation of their hosts' immune response.
227 f therapeutic vaccination combined with such immunomodulation offers an attractive avenue for the dev
228 le a clinical study to assess the effects of immunomodulation on long-term FIX expression in patients
229 , we investigated the effect of prophylactic immunomodulation on the outcome of influenza virus infec
230  crucial component influencing regeneration, immunomodulation or immuno-engineering has emerged as a
231  linked to inflammation, but whether altered immunomodulation plays a causative role in neurodegenera
232                                              Immunomodulation, primarily with immunosuppressive medic
233 fection is virus specific and is modified by immunomodulation prior to inoculation.
234  and mechanistic basis for H. pylori-induced immunomodulation, promoting persistent infection and con
235 unctions, including intercellular signaling, immunomodulation, protein maturation and processing, met
236  tissues, although its potential function in immunomodulation remains to be explored.
237                                              Immunomodulation represents a novel approach to antimicr
238 Our data indicate that this novel concept of immunomodulation represents a safer method to reduce all
239                           This SHED-mediated immunomodulation rescues OVX-induced impairment of bone
240            Concurrent with bleed management, immunomodulation should be initiated with corticosteroid
241 native approaches of combination therapy and immunomodulation should be pursued through well-designed
242 emically applied IL-22 did not display acute immunomodulation/stimulation in otherwise untreated or e
243                            Biomaterial-based immunomodulation strategies can significantly ameliorate
244 step toward the development of peptide-based immunomodulation strategies for this autoimmune disease.
245  undesirable response, we compared transient immunomodulation strategies.
246 administration of 6-TG and allopurinol as an immunomodulation strategy in inflammatory disorders.
247  release cytokines involved in apoptosis and immunomodulation, such as tumor necrosis factor-alpha an
248                                        Thus, immunomodulation targeted to activated blood vessel segm
249 pacity of IL-10KO APC and may provide unique immunomodulation targets when designing vaccines against
250 dentification of potential novel targets for immunomodulation that can be exploited therapeutically.
251  Antigen-targeted and other forms of focused immunomodulation that can suppress vessel activation and
252 ved in the clearance of B. parapertussis and immunomodulation that delays effective clearance.
253  not generally achieved by the same level of immunomodulation that is capable of inducing tolerance o
254                                   After this immunomodulation, the DBA/2 mice were given a high-phosp
255 trolled study of a device-based non-specific immunomodulation therapy (IMT) in patients with New York
256                                     Although immunomodulation therapy is promising, currently most of
257 trategies such as antifungal combination and immunomodulation therapy.
258 th of these types of dry eye will respond to immunomodulation therapy.
259                                  Amenable to immunomodulation, this interface is a unique target for
260 ndicates that for IgE-mediated food allergy, immunomodulation through food immunotherapy is possible;
261                          Cladribine provides immunomodulation through selective targeting of lymphocy
262 hat of naive T cells makes them resistant to immunomodulation, thus representing a barrier to toleran
263 ut that future studies in humans may require immunomodulation to achieve long-term expression.
264 nders this molecule an attractive target for immunomodulation to achieve tolerance to auto- and trans
265 hasone, and support the value of therapeutic immunomodulation to delay the progression to multiple my
266 ntibody responses, suggesting that transient immunomodulation to disrupt B/T-cell interaction at the
267                                              Immunomodulation to enhance systemic and local responses
268 pplemental strategies such as vaccination or immunomodulation to facilitate their persistence.
269 osed as a potential means of gene therapy or immunomodulation to treat autoimmune diseases based on e
270 d should provide targets for neuroprotective immunomodulation to treat these devastating neurodegener
271 u ammonis 1-3, and dentate gyrus) targets of immunomodulation-treated LGI1 VGKC-complex antibody-medi
272 nfluenza A/PR/8/34 virus 24 h after the last immunomodulation treatment and either monitored for surv
273                                       Future immunomodulation trials might better ascertain subjects
274 nt, underscoring the necessity to probe HCMV immunomodulation using specific T cells.
275 ugh the appropriate targets for intratumoral immunomodulation using this strategy are not known.
276                   There is a new report that immunomodulation using topical 0.05% cyclosporine A (Res
277 tivation of interleukin 1beta (IL-1beta) and immunomodulation via MyD88, the first signaling molecule
278 ed this agent could provide a novel route of immunomodulation via targeted inhibition of antigen-indu
279 endritic cells in tick-mediated Th1/Th2-cell immunomodulation was assessed.
280  cardiac allograft survival when nutritional immunomodulation was used with CsA, rapamycin (Rapa), or
281           This effect was mediated mainly by immunomodulation, which led to lower macrophage infiltra
282  interferon (IFN-gamma) production suggested immunomodulation, which was not restricted to parasite-s
283                                 This in situ immunomodulation, which was performed with low doses of
284       Novel therapeutic strategies including immunomodulation with agents like cyclosporine and angio
285                                              Immunomodulation with allogeneic cells rapidly and effic
286   These findings highlight that intratumoral immunomodulation with an oncolytic virus expressing a ra
287  some residual lesions after steroid use and immunomodulation with associated clinical recovery in pa
288  spontaneously diabetic rodents suggest that immunomodulation with autoantigens might alter the cours
289 tion for MS, because it combines features of immunomodulation with beneficial effects on neuroregener
290                                              Immunomodulation with CsA reduces the expression of cyto
291                                              Immunomodulation with cyclosporine combined with antiret
292 al differences in the effects of nutritional immunomodulation with different immunosuppressive drugs
293  we previously demonstrated that intrathymic immunomodulation with donor antigens resulted in prolong
294                                              Immunomodulation with genetically modified cells express
295  are to achieve safe and effective long-term immunomodulation with neuroprotection and repair.
296                                              Immunomodulation with SA-FasL-decorated splenocytes effe
297 ating tumor progression through intratumoral immunomodulation, with broad implications in developing
298              hRetn promoted helminth-induced immunomodulation, with increased survival of Nippostrong
299                    Current therapies involve immunomodulation, with limited effects on neuronal damag
300  in several organs with pleiotropic roles in immunomodulation, wound healing, and cell growth.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top